Digital Edition for Patient Care Online for May, 2024
Novel Web Tool Determines Consumer Eligibility for OTC Statin, With High Clinician Concordance
The web app showed more than 90% concordance with clinical assessment of eligibility for low dose rosuvastatin; study yields 35.5% reduction in LDL-C.
FDA Clears First AI-Based Algorithm to Detect Heart Failure during Routine Exams
The Low EF AI is designed to detect low ejection fraction in 15 seconds during a primary care exam.
Remotely Delivered Lipid Lowering Program Results in Sustained Target LDL-C Levels in High-Risk Population
ACC.2024: In a cohort of people at high risk of ASCVD, three-quarters achieved target LDL-C levels at 6 months and 12 months while using a remote algorithm-directed program.
